open access

Vol 50, No 6 (2016)
Original research articles
Submitted: 2016-03-14
Get Citation

The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences

Waldemar Och1, Tomasz Szmuda2, Kamil Kulbacki1, Krzysztof Witek1, Beata Sikorska3, Magdalena Zakrzewska3, Janusz Springer4, Joanna Reszeć5, Agnieszka Parda1, Paweł P Liberski3
DOI: 10.1016/j.pjnns.2016.07.001
·
Neurol Neurochir Pol 2016;50(6):395-402.
Affiliations
  1. Neurosurgery Department, Regional Specialist Hospital, Olsztyn, Poland
  2. Students’ Scientific Association, Neurosurgery Department, Medical University of Gdansk, Gdansk, Poland
  3. Department of Molecular Pathology and Neuropathology, Medical University of Łódź, Łódź, Poland
  4. Department of Preventive Medicine and Education, Medical University of Gdańsk, Gdańsk, Poland
  5. Department of Medical Pathomorphology, Medical University of Białystok, Białystok, Poland

open access

Vol 50, No 6 (2016)
Original research articles
Submitted: 2016-03-14

Abstract

Meningiomas (MGs) are the frequent benign intracranial tumors. Their complete removal does not always guarantee relapse-free survival. Recurrence-associated chromosomal anomalies in MGs haves been proposed as prognostic factors in addition to the World Health Organisation (WHO) grading, tumor size and resection rate. The aim of this study was to evaluate the frequency of deletions on chromosomes in sporadic MGs and to correlate them with the clinical findings and tumor behaviour. Along with survival, the tumor recurrence was the main endpoint. Chromosomal loss of heterozygosity (LOH) was studied. 46 benign MGs were subjected to the analysis, complete tumor resection was intended and no early mortalities were observed. Incomplete removal was related to parasagittal location and psammomatous hisptopathology (p<0.01). Chromosomal alterations were present in 82.6% of cases; LOH at 22q (67.4%) and 1p (34.8%) were the most frequent and associated with male sex (p=0.04). Molecular findings were not specific for any of the histopathologic grade. Tumor recurrence (14 of 46) correlated with tumor size (≥35mm), LOH at 1p, 14q, coexistence of LOH at 1p/14q, 10q/14q, ‘complex karyotype’ status (≥2 LOHs excluding 22q), patient age (younger <35), and Simpson grading of resection rate (≥3 of worse prognosis). The last 3 variables were independent significant prognostic factors in multivariate analysis and of the same importance in recurrence prediction (Receiver Operating Characteristic curves comparison p>0.05). Among the cases of recurrence, tumor progression was observed in 3 of 14. In 2 cases, LOH on 1p and/or coexistence of LOH 1p/14q correlated with anaplastic transformation.

Abstract

Meningiomas (MGs) are the frequent benign intracranial tumors. Their complete removal does not always guarantee relapse-free survival. Recurrence-associated chromosomal anomalies in MGs haves been proposed as prognostic factors in addition to the World Health Organisation (WHO) grading, tumor size and resection rate. The aim of this study was to evaluate the frequency of deletions on chromosomes in sporadic MGs and to correlate them with the clinical findings and tumor behaviour. Along with survival, the tumor recurrence was the main endpoint. Chromosomal loss of heterozygosity (LOH) was studied. 46 benign MGs were subjected to the analysis, complete tumor resection was intended and no early mortalities were observed. Incomplete removal was related to parasagittal location and psammomatous hisptopathology (p<0.01). Chromosomal alterations were present in 82.6% of cases; LOH at 22q (67.4%) and 1p (34.8%) were the most frequent and associated with male sex (p=0.04). Molecular findings were not specific for any of the histopathologic grade. Tumor recurrence (14 of 46) correlated with tumor size (≥35mm), LOH at 1p, 14q, coexistence of LOH at 1p/14q, 10q/14q, ‘complex karyotype’ status (≥2 LOHs excluding 22q), patient age (younger <35), and Simpson grading of resection rate (≥3 of worse prognosis). The last 3 variables were independent significant prognostic factors in multivariate analysis and of the same importance in recurrence prediction (Receiver Operating Characteristic curves comparison p>0.05). Among the cases of recurrence, tumor progression was observed in 3 of 14. In 2 cases, LOH on 1p and/or coexistence of LOH 1p/14q correlated with anaplastic transformation.

Get Citation

Keywords

Meningioma, Loss of heterozygosity, LOH, Tumour recurrence

About this article
Title

The correlation of clinical and chromosomal alterations of benign meningiomas and their recurrences

Journal

Neurologia i Neurochirurgia Polska

Issue

Vol 50, No 6 (2016)

Pages

395-402

Page views

371

Article views/downloads

523

DOI

10.1016/j.pjnns.2016.07.001

Bibliographic record

Neurol Neurochir Pol 2016;50(6):395-402.

Keywords

Meningioma
Loss of heterozygosity
LOH
Tumour recurrence

Authors

Waldemar Och
Tomasz Szmuda
Kamil Kulbacki
Krzysztof Witek
Beata Sikorska
Magdalena Zakrzewska
Janusz Springer
Joanna Reszeć
Agnieszka Parda
Paweł P Liberski

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl